newsfilter
← Latest News
PR Newswire·

BioSpecifics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with ...